RBx-6198

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRBx-6198
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRanbaxy Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRanbaxy Laboratories
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A